XiaoEr LianHuaQinqGan alleviates viral pneumonia in mice infected by influenza A and respiratory syncytial viruses.

Wenyan LiTongtong LiChi ZhaoTao SongYao MiZhang ChuangfengYun-Long Hou Zhen-Hua Jia

Published in: Pharmaceutical biology (2022)

XELH efficacy partially depends on integrated immunoregulatory effects. XELH is a promising therapeutic option against childhood respiratory viral infections.

Keyphrases

sars cov
respiratory tract
high fat diet induced
mouse model
early life
metabolic syndrome
young adults
skeletal muscle
respiratory failure